Fenwick & West represented Day One Biopharmaceuticals in the transaction. Day One Biopharmaceuticals (Nasdaq: DAWN) (“Day One”), a commercial-stage biopharmaceutical company announced its exclusive licensing agreement...
Day One Biopharmaceuticals’ License Agreement with MabCare Therapeutics
The Engine Ventures’ $398 Million Closing of Fund III
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented The Engine Ventures in the transaction. The Engine Ventures, a venture firm, announced the formation of Fund III,...
NexCore’s Acquisition of Kennedy Mechanical and Ryan Plumbing & Heating
Kirkland & Ellis advised NexCore on the transaction, and Harter Secrest & Emery advised Kennedy Mechanical Plumbing & Heating. NexCore, a commercial HVAC service platform backed...
Honeywell’s $1.9 Billion Acquisition of CAES Systems Holdings
Skadden is advising Honeywell in the transaction. Honeywell has agreed to acquire CAES Systems Holdings LLC (CAES) from private equity firm Advent International for approximately $1.9...
Microsoft’s Acquisition of 8 Million Carbon Removal Credits from BTG Pactual Timberland Investment Group
Gibson, Dunn & Crutcher LLP advised BTG Pactual Timberland Investment Group on the deal. The BTG Pactual Timberland Investment Group (TIG) announced the execution of a...
Vestis Corporation’s Board Of Directors
The Hogan Lovells deal team of partners John Beckman (Picture) and Rupa Briggs, and associate Leia Scott represented Vestis. Vestis Corporation (NYSE: VSTS), a leading provider...
Community Health Systems’ $1.225 Billion High-Yield Senior Secured Notes Offering
Simpson Thacher & Bartlett represented CHS/Community Health Systems, Inc. in the offering, and Cravath Swaine & Moore represented the initial purchasers. CHS/Community Health Systems, Inc. (the...
H.I.G. Growth’s Acquisition of Mobile Health
Wilson Sonsini Goodrich & Rosati advised Mobile Health on the transaction, while Paul Hastings and Bass, Berry & Sims advised H.I.G. Growth Partners. H.I.G. Growth Partners...
Genpact’s $400 Million Senior Notes Offering
Cravath, Swaine & Moore advised Genpact Luxembourg S.à r.l. and Genpact USA, Inc. on the offering, and Simpson Thacher & Bartlett advised the underwriters. Genpact USA,...
Iambic Therapeutics’ $50 Million Series B Extension Financing
Wilson Sonsini Goodrich & Rosati advised Iambic Therapeutics on the transaction. Iambic Therapeutics (Iambic), a clinical-stage biotechnology company, announced the closing of an oversubscribed $50 million...
Avidity Biosciences’ $461 Million Common Stock Offering
Latham & Watkins advised Avidity Biosciences, Inc. on the offering, and Wilson Sonsini Goodrich & Rosati advised Avidity on patent matters related to the transaction. Cooley...
Disc Medicine’s $178 Million Common Stock Offering
Goodwin Procter advised Disc Medicine, Inc. on the offering, and Wilmer Cutler Pickering Hale and Dorr advised the underwriter. Disc Medicine, Inc. (Nasdaq: IRON) (“Disc”) announced...